| Disease Name |
ICD 11 |
Studied Tissue |
p-value |
Fold-Change |
Z-score |
|
Acute myelocytic leukaemia
|
2B33.1 |
Bone marrow |
3.55E-03
|
8.66E-02
|
3.39E-01 |
|
Alzheimer's disease
|
8A20 |
Entorhinal cortex |
1.72E-05
|
1.56E-01
|
5.66E-01 |
|
Asthma
|
CA23 |
Nasal and bronchial airway |
7.71E-01
|
-1.59E-02
|
-4.62E-02 |
|
Behcet's disease
|
4A62 |
Peripheral blood |
7.46E-01
|
-7.35E-02
|
-2.68E-01 |
|
Bipolar disorder
|
6A60-6A6Z |
Prefrontal cortex |
8.08E-01
|
-5.02E-02
|
-3.13E-01 |
|
Bladder cancer
|
2C94 |
Bladder tissue |
8.26E-03
|
-4.25E-01
|
-1.52E+00 |
|
Breast cancer
|
2C60-2C6Z |
Breast tissue |
9.56E-01
|
-6.56E-02
|
-1.60E-01 |
|
Colon cancer
|
2B90 |
Colon tissue |
2.94E-11
|
-2.25E-01
|
-6.93E-01 |
|
Diffuse large B-cell lymphoma
|
2A81 |
Tonsil tissue |
6.57E-02
|
-2.53E-01
|
-1.32E+00 |
|
Familial hypercholesterolemia
|
5C80.00 |
Peripheral blood |
4.52E-01
|
-3.67E-02
|
-1.49E-01 |
|
Gastric cancer
|
2B72 |
Gastric tissue |
3.91E-01
|
-1.74E-01
|
-9.98E-01 |
|
Glioblastopma
|
2A00.00 |
Nervous tissue |
1.37E-13
|
-1.59E-01
|
-4.10E-01 |
|
Head and neck cancer
|
2D42 |
Head and neck tissue |
4.71E-10
|
2.49E-01
|
7.11E-01 |
|
HIV-associated neurocognitive impairment
|
8A2Y-8A2Z |
White matter tissue |
2.15E-01
|
6.24E-02
|
3.38E-01 |
|
Idiopathic pulmonary fibrosis
|
CB03.4 |
Lung tissue |
9.08E-01
|
1.70E-01
|
3.56E-01 |
|
Interstitial cystitis
|
GC00.3 |
Bladder tissue |
6.48E-02
|
-3.82E-01
|
-1.09E+00 |
|
Ischemic stroke
|
8B11 |
Peripheral blood |
3.92E-01
|
5.52E-02
|
4.06E-01 |
|
Liver cancer
|
2C12.0 |
Liver tissue |
1.20E-09
|
-1.33E+00
|
-1.57E+00 |
|
Liver failure
|
DB99.7-DB99.8 |
Liver tissue |
4.59E-01
|
-3.25E-01
|
-4.40E-01 |
|
Lung cancer
|
2C25 |
Lung tissue |
1.95E-13
|
-3.00E-01
|
-7.35E-01 |
|
Lupus erythematosus
|
4A40 |
Whole blood |
9.37E-04
|
-1.53E-01
|
-3.24E-01 |
|
Major depressive disorder
|
6A70-6A7Z |
Hippocampus |
4.83E-02
|
-1.13E-01
|
-7.42E-01 |
|
Multiple myeloma
|
2A83.1 |
Bone marrow |
4.03E-02
|
2.80E-01
|
9.12E-01 |
|
Multiple myeloma
|
2A83.1 |
Peripheral blood |
4.76E-01
|
-3.39E-02
|
-1.59E-01 |
|
Multiple sclerosis
|
8A40 |
Plasmacytoid dendritic cells |
5.30E-02
|
9.95E-02
|
8.37E-01 |
|
Myelodysplastic syndrome
|
2A36-2A3Z |
Bone marrow |
6.15E-02
|
1.83E-01
|
4.37E-01 |
|
Myocardial infarction
|
BA41-BA50 |
Peripheral blood |
5.48E-02
|
1.23E-01
|
3.90E-01 |
|
Neuroectodermal tumour
|
2A00.11 |
Brain stem tissue |
8.25E-11
|
-1.40E+00
|
-5.41E+00 |
|
Non-alcoholic fatty liver disease
|
DB92 |
Liver tissue |
1.07E-01
|
3.51E-01
|
6.18E-01 |
|
Obesity related type 2 diabetes
|
5A11 |
Omental adipose tissue |
7.57E-01
|
1.13E-01
|
7.40E-01 |
|
Olive pollen allergy
|
CA08.00 |
Peripheral blood |
1.54E-01
|
2.83E-01
|
9.68E-01 |
|
Oral cancer
|
2B6E |
Oral tissue |
2.65E-03
|
-3.55E-01
|
-7.20E-01 |
|
Ovarian cancer
|
2C73 |
Ovarian tissue |
3.81E-06
|
-8.12E-01
|
-3.58E+00 |
|
Pancreatic cancer
|
2C10 |
Pancreas |
1.08E-02
|
4.00E-01
|
9.42E-01 |
|
Parkinson's disease
|
8A00.0 |
Substantia nigra tissue |
4.80E-01
|
1.83E-01
|
5.30E-01 |
|
Pituitary cancer
|
2D12 |
Pituitary tissue |
5.07E-06
|
7.73E-01
|
2.60E+00 |
|
Polycystic ovary syndrome
|
5A80.1 |
Vastus lateralis muscle |
1.29E-01
|
-4.73E-02
|
-2.30E-01 |
|
Pompe disease
|
5C51.3 |
Biceps muscle |
6.23E-03
|
3.28E-01
|
2.64E+00 |
|
Prostate cancer
|
2C82 |
Prostate |
9.80E-02
|
-4.63E-01
|
-7.10E-01 |
|
Psoriasis
|
EA90 |
Skin |
2.06E-12
|
-2.34E-01
|
-5.86E-01 |
|
Rectal cancer
|
2B92 |
Rectal colon tissue |
6.23E-02
|
-1.90E-01
|
-8.95E-01 |
|
Renal cancer
|
2C90-2C91 |
Kidney |
9.15E-02
|
-5.83E-01
|
-7.76E-01 |
|
Retinoblastoma
|
2D02.2 |
Uvea |
3.17E-07
|
1.74E+00
|
4.39E+00 |
|
Schizophrenia
|
6A20 |
Prefrontal cortex |
9.58E-02
|
-1.47E-01
|
-3.81E-01 |
|
Schizophrenia
|
6A20 |
Superior temporal cortex |
4.73E-01
|
-2.24E-02
|
-1.34E-01 |
|
Scleroderma
|
4A42.Z |
Whole blood |
7.55E-06
|
-2.64E-01
|
-2.44E+00 |
|
Seizure
|
8A60-8A6Z |
Whole blood |
9.77E-01
|
-1.42E-01
|
-5.03E-01 |
|
Sepsis with septic shock
|
1G41 |
Whole blood |
9.73E-02
|
7.42E-02
|
2.61E-01 |
|
Sickle cell disease
|
3A51.0-3A51.3 |
Peripheral blood |
5.22E-01
|
1.22E-01
|
3.10E-01 |
|
Simpson golabi behmel syndrome
|
LD2C |
Adipose tissue |
8.79E-01
|
-1.01E-01
|
-1.59E-01 |
|
Sjogren's syndrome
|
4A43.2 |
Salivary gland tissue |
3.30E-01
|
4.05E-01
|
1.15E+00 |
|
Skin cancer
|
2C30-2C3Z |
Skin |
3.67E-07
|
1.12E-01
|
2.28E-01 |
|
Thrombocythemia
|
3B63 |
Whole blood |
7.96E-02
|
1.06E-01
|
6.60E-01 |
|
Thrombocytopenia
|
3B64 |
Whole blood |
4.44E-01
|
2.71E-01
|
5.56E-01 |
|
Thyroid cancer
|
2D10 |
Thyroid |
3.50E-20
|
-8.89E-01
|
-1.93E+00 |
|
Tibial muscular dystrophy
|
8C75 |
Muscle tissue |
1.29E-02
|
-1.32E-01
|
-5.26E-01 |
|
Tuberous sclerosis complex
|
LD2D.2 |
Perituberal tissue |
9.91E-02
|
4.40E-01
|
1.83E+00 |
|
Type 2 diabetes
|
5A11 |
Liver tissue |
1.96E-01
|
-2.61E-01
|
-1.17E+00 |
|
Ureter cancer
|
2C92 |
Urothelium |
5.02E-01
|
1.12E-01
|
3.98E-01 |
|
Uterine cancer
|
2C78 |
Endometrium tissue |
2.88E-04
|
-4.08E-01
|
-5.61E-01 |
|
Vitiligo
|
ED63.0 |
Skin |
2.25E-01
|
-3.41E-02
|
-9.35E-02 |
| ------------------------------------------------------------------------------------ |
|
|
|
|
|
